AI Article Synopsis
- This study evaluated how French infection specialists' antibiotic therapy duration advice changed between 2016 and 2018, through two surveys involving 325 hospital-based specialists.
- Results showed a significant increase in the recommendation of shorter antibiotic courses in 2018, with 71% of respondents supporting this change compared to 46% in 2016.
- The presence of updated guidelines seemed to positively influence these specialists, as most reported being aware of a recommendation for shorter treatment durations from 2017.
Article Abstract
Objective: To compare the practices of French infection specialists related to antibiotic therapy duration between 2016 and 2018.
Methods: We conducted two identical surveys (in 2016 and 2018) targeting hospital-based infection specialists (medical physicians, pharmacists) who gave at least weekly advice on antibiotic prescriptions. The questionnaire included 15 clinical vignettes. Part A asked about the durations of antibiotic therapies they would usually advise to prescribers, and part B asked about the shortest duration they would be willing to advise for the same clinical situations.
Results: We included 325 specialists (165 in 2016 and 160 in 2018), mostly infectious disease specialists (82.4%, 268/325), members of antibiotic stewardship teams in 72% (234/325) of cases. Shorter antibiotic treatments (as compared with the literature) were advised to prescribers in more than half of the vignettes by 71% (105/147) of respondents in 2018, versus 46% (69/150) in 2016 (P<0.001). Guidelines used by participants displayed fixed durations for 77% (123/160) of cases in 2018 versus 21% (35/165) in 2016. Almost all respondents (89%, 131/160) declared they were aware of the 2017 SPILF's proposal.
Conclusion: The release of guidelines promoting shorter durations of antibiotic therapy seems to have had a favourable impact on practices of specialists giving advice on antibiotic prescriptions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.medmal.2019.07.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Length of hospital stay not affected by empirical treatment with ceftriaxone versus cefuroxime for bacteraemia.
Acta Paediatr
January 2025
Pediatric Department, Laniado Hospital, Netanya, Israel.
Aim: The preferred antibiotic treatment for bacteraemia in infants continues to be debated. We examined the duration of hospital stays as a surrogate for the effectiveness of initial treatment with ceftriaxone versus cefuroxime.
Methods: This was a retrospective review of the medical records of all infants aged 3-36 months, admitted with suspected occult bacteraemia to the paediatric department at Laniado Hospital, Israel, between 2016 and 2022.
Impact of 24-hour pharmacy call response on time to antibiotics in open fractures.
Am J Health Syst Pharm
January 2025
Department of Pharmacy, Medical University of South Carolina Health, Charleston, SC, USA.
Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
View Article and Find Full Text PDFPrognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris.
Acta Derm Venereol
January 2025
Department of Dermatology, Sheba Medical Center, Tel HaShomer, Ramat Gan, Israel.
Pemphigus vulgaris is a chronic autoimmune blistering disease with significant morbidity. Rituximab, approved as its first-line treatment, effectively induces remission. However, few studies have analysed the prognostic factors for improved rituximab outcomes.
View Article and Find Full Text PDFAntibiotic Length of Therapy: Is Shorter Better in Older Adults?
Sr Care Pharm
January 2025
3 Palm Beach Atlantic University Gregory School of Pharmacy, West Palm Beach, Florida.
Antibiotic lengths of therapy (LOT) vary widely, based on infection type, antibiotic regimen, and patient characteristics. Longer LOT are associated with increased risk of antibiotic resistance, adverse effects, and health care costs. There are increasing data supporting shorter LOT for many infections based on randomized, controlled trials (RCTs).
View Article and Find Full Text PDFResults of treating patients with cellulitis by hyperbaric oxygen: a case-control study.
Int Marit Health
January 2025
Institute of Maritime Medicine, Hai Phong, Vietnam, 21 Vo Nguyen Giap, Le Chan, Kenh Duong, Hai Phong, Vietnam, 18000 Hai Phong, Viet Nam.
Background: Cellulitis is an acute bacterial infection of the skin and subcutaneous tissue. The characteristic symptoms of the disease are an area of skin that is swollen, warmth, redness, pain, unknown borderline, tends to expand, and can lead to tissue necrosis. Hyperbaric Oxygen (HBO) is a non-drug treatment, which has the effect of relieving pain, reducing edema, and accelerating the wound healing process for patients with cellulitis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!